Search Results - "Hovels, A"

Refine Results
  1. 1

    Does conditional approval for new oncology drugs in Europe lead to differences in health technology assessment decisions? by Lipska, I, Hoekman, J, McAuslane, N, Leufkens, HGM, Hövels, AM

    Published in Clinical pharmacology and therapeutics (01-11-2015)
    “…An early access pathway of conditional approval for potentially beneficial medicines is available within the European regulatory framework. However, marketing…”
    Get full text
    Journal Article
  2. 2

    Individuals with filaggrin‐related eczema and asthma have increased long‐term medication and hospital admission costs by Soares, P., Fidler, K., Felton, J., Tavendale, R., Hövels, A., Bremner, S.A., Palmer, C.N.A., Mukhopadhyay, S.

    Published in British journal of dermatology (1951) (01-09-2018)
    “…Summary Background Eczema and asthma are chronic diseases with onset usually before the age of 5 years. More than 50% of individuals with eczema will develop…”
    Get full text
    Journal Article
  3. 3

    Changing costs of metastatic non small cell lung cancer in the Netherlands by Keusters, W.R., de Weger, V.A., Hövels, A., Schellens, J.H.M., Frederix, G.W.J.

    Published in Lung cancer (Amsterdam, Netherlands) (01-12-2017)
    “…•A Cost of illness study on non-small cell lung cancer is conducted.•Cost on non-small cell lung cancer have decreased in recent years.•Oncolytic drugs have…”
    Get full text
    Journal Article
  4. 4

    The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis by Hövels, A.M, Heesakkers, R.A.M, Adang, E.M, Jager, G.J, Strum, S, Hoogeveen, Y.L, Severens, J.L, Barentsz, J.O

    Published in Clinical radiology (01-04-2008)
    “…Aim To compare the diagnostic accuracy of computed tomography (CT) and magnetic resonance imaging (MRI) in the diagnosis of lymph node metastases in prostate…”
    Get full text
    Journal Article
  5. 5

    NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands by van den Heuvel, J M, Hövels, A M, Büller, H R, Mantel-Teeuwisse, A K, de Boer, A, Maitland-van der Zee, A H

    Published in Thrombosis journal (18-04-2018)
    “…In 2012, around 400.000 patients in the Netherlands were treated with Vitamin K Antagonists (VKA) for thromboembolic diseases. Since 2011, non-VKA oral…”
    Get full text
    Journal Article
  6. 6

    Cost-effectiveness of monitoring endoxifen levels in breast cancer patients adjuvantly treated with tamoxifen by van Nuland, M., Vreman, R. A., ten Ham, R. M. T., de Vries Schultink, A. H. M., Rosing, H., Schellens, J. H. M., Beijnen, J. H., Hövels, A. M.

    Published in Breast cancer research and treatment (01-11-2018)
    “…Purpose Breast cancer is the most common malignancy in women worldwide. Recurrence rates in breast cancer are considered to be dependent on the serum…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Increased medication costs for filaggrin‐related eczema and asthma by Soares, P., Fidler, K., Felton, J., Tavendale, R., Hövels, A., Bremner, S.A., Palmer, C.N.A., Mukhopadhyay, S.

    Published in British journal of dermatology (1951) (01-09-2018)
    “…Summary Eczema and asthma are common chronic diseases. Eczema affects 15‐20% of schoolchildren and 2‐10% of adults while asthma affects 16‐18% of the UK…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Time-dependent resource use and costs associated with different states of disease in patients diagnosed with HER-2-positive metastatic breast cancer by Frederix, G. W. J., Severens, J. L., Hövels, A. M., van Hasselt, J. G. C., Raaijmakers, J. A. M., Schellens, J. H. M.

    Published in Breast cancer research and treatment (01-06-2013)
    “…Adequate reflection of disease progression and costs over time is essential in cost-effectiveness analyses based on health state-transition models. However,…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    The Introduction Of A Threshold For The Icer And The Implications For Reimbursement Of Drugs In The Dutch Healthcare System by Karpenko, AW, Geenen, JW, Vreman, RA, Hovels, A

    Published in Value in health (01-10-2017)
    “…OBJECTIVES: The National Health Care Institute (ZIN) advises the minister of healthcare (MOH) if a drug should be reimbursed. Recently it was suggested to…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20